FDA Warns: Government-Funded COVID-19 Test Not On Cue

The US FDA is warning against the use of Cue Health’s COVID-19 test, which was developed and manufactured with $481m of government funding. A recent inspection found unauthorized alterations to the product.

Cue Health's COVID-19 OTC molecular test has been approved at home.
• Source: Shutterstock

Patients and providers should not use COVID-19 tests from Cue Health because they may be inaccurate, the US Food and Drug Administration warned on 13 May.

More from Regulation

More from Policy & Regulation